These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 11877611)
1. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low--molecular weight heparin. Michot M; Conen D; Holtz D; Erni D; Zumstein MD; Ruflin GB; Renner N Arthroscopy; 2002 Mar; 18(3):257-63. PubMed ID: 11877611 [TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM; Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046 [TBL] [Abstract][Full Text] [Related]
3. Deep venous thrombosis after knee arthroscopy: a systematic review and meta-analysis. Sun Y; Chen D; Xu Z; Shi D; Dai J; Qin J; Qin J; Jiang Q Arthroscopy; 2014 Mar; 30(3):406-12. PubMed ID: 24581264 [TBL] [Abstract][Full Text] [Related]
4. Prevention of Venous Thromboembolism after Arthroscopic Knee Surgery in a Low-Risk Population with the Use of Aspirin. A Randomized Trial. Kaye ID; Patel DN; Strauss EJ; Alaia MJ; Garofolo G; Martinez A; Jazrawi LM Bull Hosp Jt Dis (2013); 2015 Dec; 73(4):243-8. PubMed ID: 26630467 [TBL] [Abstract][Full Text] [Related]
5. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial. Wirth T; Schneider B; Misselwitz F; Lomb M; Tüylü H; Egbring R; Griss P Arthroscopy; 2001 Apr; 17(4):393-9. PubMed ID: 11288011 [TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis. Lameire DL; Khalik HA; Phillips M; MacDonald AE; Banfield L; de Sa D; Ayeni OR; Peterson D Knee Surg Sports Traumatol Arthrosc; 2022 Jul; 30(7):2364-2376. PubMed ID: 35112181 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group. Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis. Huang HF; Tian JL; Yang XT; Sun L; Hu RY; Yan ZH; Li SS; Xie Q; Tian XB PLoS One; 2018; 13(6):e0197868. PubMed ID: 29927930 [TBL] [Abstract][Full Text] [Related]
11. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
12. Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism. Wellington K; McClellan K; Jarvis B Drugs; 2001; 61(8):1185-209. PubMed ID: 11465877 [TBL] [Abstract][Full Text] [Related]
13. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068 [TBL] [Abstract][Full Text] [Related]
14. Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials. Chapelle C; Rosencher N; Jacques Zufferey P; Mismetti P; Cucherat M; Laporte S; Arthroscopy; 2014 Aug; 30(8):987-96. PubMed ID: 24813323 [TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. De A; Roy P; Garg VK; Pandey NK Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449 [TBL] [Abstract][Full Text] [Related]
17. The effect of anticoagulants on venous thrombosis prevention after knee arthroscopy: a systematic review. Huang HF; Tian JL; Sun L; Yang XT; Shen YK; Li SS; Xie Q; Tian XB Int Orthop; 2019 Oct; 43(10):2303-2308. PubMed ID: 30377699 [TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis. Lu X; Lin J BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575 [TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. Holzheimer RG Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403 [TBL] [Abstract][Full Text] [Related]
20. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Kamphuisen PW; Agnelli G Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]